For most men, hair loss doesn't come as a surprise so much as a slow, creeping realization—a higher hairline in photos, more visible scalp under bright light, a thinning crown you only notice in the mirror at just the right angle. Male pattern baldness affects the majority of men to some degree by their 50s, yet many still don't fully understand what's actually happening to their hair—or that effective, evidence-based treatment options exist.
Male pattern baldness, medically known as androgenetic alopecia, is the most common cause of hair loss in men. Unlike hair thinning caused by stress or nutritional deficiencies, pattern baldness follows a predictable, progressive pattern—typically starting at the temples and crown before potentially advancing further over time.
Male pattern baldness is driven primarily by a combination of genetics and a hormone called dihydrotestosterone (DHT). DHT is a byproduct of testosterone, and in genetically susceptible hair follicles, it binds to receptors and gradually shrinks them in a process called follicular miniaturization.
Over time, miniaturized follicles produce thinner, shorter hairs, until eventually they stop producing visible hair altogether. This is why pattern baldness tends to run in families—the genetic sensitivity of your hair follicles to DHT is largely inherited.
A common misconception is that because pattern baldness is genetic, it's simply unavoidable or untreatable. In reality, understanding the DHT mechanism has led to effective, well-researched treatments that directly address the underlying cause—not just the symptoms.
Male pattern baldness typically follows a few common progressions:
Recognizing early signs allows for earlier intervention, which is generally associated with better outcomes than waiting until hair loss has significantly progressed.
Since DHT is the primary driver of pattern baldness, the most effective treatments work by targeting this mechanism directly. Finasteride is one of the most well-researched treatment options available, working by reducing DHT levels in the body. Taken once daily, it helps slow further follicle miniaturization and supports hair retention, with most men seeing results over 3–6 months of consistent use.
Beyond addressing DHT internally, supporting the scalp environment itself can complement treatment. GHK-Cu Cream, formulated with copper peptides, is designed to support renewal at the follicle level, making it a useful addition alongside DHT-targeted treatment.
Hair follicles that have been fully miniaturized for an extended period are more difficult to revive than follicles caught earlier in the process. This is why many providers emphasize starting treatment as soon as thinning is noticed, rather than waiting to see how far it progresses.
Treatment for pattern baldness is generally most effective at slowing further loss and supporting retention of existing hair, rather than fully reversing significant, long-standing baldness. Many men also see meaningful regrowth in areas of more recent thinning, but individual results vary based on genetics, timing, and consistency with treatment.
Pattern baldness affects an enormous percentage of men and is driven by biology, not lifestyle choices or personal shortcomings. Approaching it as a treatable medical condition—rather than something to simply accept or feel embarrassed about—opens the door to real, evidence-based solutions.
Male pattern baldness is a genetic, hormone-driven condition—but understanding the underlying DHT mechanism has led to effective treatments that address the actual cause, not just the appearance. Starting treatment early, staying consistent, and working with a healthcare provider can make a meaningful difference in outcomes.
Noticing early signs of hair loss? Connect with a Society provider to explore your treatment options.
.png)
.png)
.svg)
.svg)
